A Phase 3 Study Of SU011248 In Combination With Paclitaxel Versus Bevacizumab With Paclitaxel In The First-Line Advanced Disease Setting In Patients Having Breast Cancer.
Phase of Trial: Phase III
Latest Information Update: 07 Sep 2012
At a glance
- Drugs Bevacizumab; Paclitaxel; Sunitinib
- Indications Advanced breast cancer
- Focus Biomarker; Registrational; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Jun 2011 Planned end date changed from 1 Jun 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.
- 19 Jan 2011 Planned end date changed from 1 Jan 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.